Illustrative scenarios for SMI intermediary relationship

To ensure and improve patient and clinician access to innovative, reliable, and effective medical technologies, it is often necessary for Companies to engage third parties to assist in the marketing, sale, and/or distribution of the Companies’ products or services. It is essential that Companies’ interactions with SMIs, as well as SMIs’ activities on behalf of Companies (including SMI interactions with HCPs and government officials), are conducted pursuant to all applicable legal requirements and comply with ethical standards equivalent to those in the applicable Industry Codes of Ethics

Posted on 04.10.2017

Illustrative scenarios

Related content

News Ethical MedTech Interactions with the Medical Community MedTech Europe MedTech Europe Code Newsletter

MedTech Europe Code of Ethical Business Practice

Posted on 07.07.2022

Read more
News Ethical MedTech Interactions with the Medical Community MedTech Europe MedTech Europe Code Newsletter

Revised Code of Ethical Business Practice approved

Posted on 06.04.2022

Read more